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Abstract
The receptor for advanced glycation endproducts (RAGE) has
complex roles in the immune/inflammatory response. RAGE is
expressed on monocytes/macrophages, T and B lymphocytes, and
dendritic cells. Previous studies illustrated that homozygous
RAGE–/– mice subjected to overwhelming bacterial sepsis
displayed normal clearance of pathogenic bacteria and significantly
increased survival. In this issue of Critical Care, Lutterloh and
colleagues confirm these findings and provide evidence that
blocking antibodies to RAGE afford similar protection in mice, even
when administration of anti-RAGE is delayed by 24 hours.
Furthermore, these authors illustrate that deletion of RAGE  is
remarkably protective in mice infected with the intracellular
pathogen  Listeria monocytogenes. In this Commentary, we
consider these findings and propose possible mechanisms by
which RAGE exacts a heavy toll on the host in response to
polymicrobial sepsis and L. monocytogenes.
The receptor for advanced glycation endproducts (RAGE)
plays central roles in the immune/inflammatory response. In
this issue of Critical Care, Lutterloh and colleagues [1] tested
roles for RAGE in two distinct models of severe infection in
mice: (a) that induced by cecal ligation and puncture and (b)
overwhelming infection with Listeria monocytogenes. RAGE
is a multi-ligand receptor that binds fundamental regulatory
molecules of inflammatory responses, the S100/calgranulins
and high-mobility group box-1 (HMGB-1). The beneficial
effects of ligand-RAGE blockade were observed in delayed-
type hypersensitivity reactions, collagen-induced arthritis,
experimental autoimmune encephalomyelitis, and alloimmunity,
for example [2]. RAGE is expressed by multiple cell types
implicated in the immune/inflammatory response, such as
monocytes/macrophages, T and B lymphocytes, and
dendritic cells. Ligand-RAGE interaction activates mono-
cytes/macrophages, and recent studies provide compelling
evidence for the role of RAGE in effective T-lymphocyte
priming. In vivo and in vitro, T lymphocytes devoid of RAGE
display markedly reduced proliferative and cytokine
responses (interferon-γ and interleukin-2) to nominal or allo-
antigen [3]. Lutterloh and colleagues show that RAGE is not
essential for clearance of pathogenic bacteria in poly-
microbial sepsis or to L. monocytogenes. Rather, they illus-
trate that deletion of RAGE enhances survival compared with
wild-type mice. How may we explain these findings?
In confirming the results of others in RAGE–/– mice [4], these
authors showed that homozygous or heterozygous deletion of
the RAGE gene was strongly protective in mice subjected to
cecal ligation and puncture. Furthermore, administration of
blocking monoclonal antibodies to RAGE, even when delayed
by 24 hours, afforded survival benefit in mice subjected to
this procedure. These data provide compelling evidence that
RAGE is not required for fundamental innate responses that
clear bacteria. Rather, RAGE may mediate hyperinflammatory
responses to the invading bacteria that are injurious to the
host. Clues that this is a likely explanation have come from the
novel findings of Lutterloh and colleagues in L. monocyto-
genes-challenged RAGE–/– mice.
These authors challenged mice with L. monocytogenes and
report that RAGE–/– mice or RAGE+/– mice displayed an
LD50 (median lethal dose) that was more than two orders of
magnitude higher than that of wild-type mice. In BALB/c
mice, administration of anti-RAGE antibody offered significant
protection against listeriosis. Importantly, bacterial counts did
not differ among RAGE–/– and antibody-treated mice
compared with controls.
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As recently reviewed by Pamer [5], in the first few days of
Listeria  infection, the innate response is critical for early
bacterial clearance and host survival. The adaptive response
instead is required for controlling chronic, but not acute,
infection since SCID (severe combined immunodeficiency
disease) mice survive early listeriosis normally, but ultimately
this infection is lethal due to long-term failure to clear the
organism [6,7]. In the initial phase of infection, Listeria binds to
splenic macrophages and is internalized; Listeria  produces
products that activate nuclear factor-kappa B and upregulate
innate immune molecules such as CC-chemokine ligand
CCL2 [5]. Infected macrophages then release microbial
products and engage Toll-like receptors (TLRs). Via myeloid
differentiation factor 88 (Myd88), these macrophages differen-
tiate into TNF (tumor necrosis factor)- and iNOS (inducible
nitric oxide synthase)-producing cells that directly promote
bacterial killing. Innate immune responses are thoroughly
essential for host survival to Listeria as mice deficient in
Myd88 are exquisitely vulnerable to this bacterium [8].
Interestingly, mice deficient in either TLR-2 or TLR-4 display
relatively normal resistance to Listeria [8,9], suggesting that
compensation by other TLRs may override the loss of a single
TLR and permit macrophage activation and bacterial killing.
Unlike the TLRs, RAGE is not likely to be activated directly by
microbial products. However, RAGE ligands inducibly
expressed upon macrophage activation may potentiate initial
innate activation and the systemic inflammatory response.
It is well established that in listeriosis, production of inter-
feron-γ presumably by natural killer cells or T lymphocytes is
critical for macrophage activation and initial bacterial
clearance as well as for promotion of long-term protective
cellular immunity [10]. Herein lies an intriguing piece of the
puzzle; RAGE–/– mice displayed strikingly decreased levels of
interferon-γ compared with wild-type mice in listeriosis yet
were significantly protected from the injurious effects of the
microorganism. In addition to revealing that production of this
cytokine is not absolutely linked to the initial clearance of L.
monocytogenes, these findings are consistent with the notion
that the RAGE-induced proinflammatory state may be
deleterious in the early stages of infection yet may ultimately
promote protective adaptive Th1 cellular immunity. Thus, we
may predict that deletion of RAGE or RAGE blockade
suppresses interferon-γ-propagated macrophage activation
and the hyperinflammation response that injures the host.
However, since RAGE is critical for the Th1 adaptive
response [3], it will be important to address the effect of
RAGE deficiency or blockade on long-term anti-Listeria
immunity. Note that Lutterloh and colleagues examined
interferon-γ levels at 48 hours post-infection and in plasma
only, not tissue. Thus, it remains possible that levels of this
cytokine in RAGE–/– mice might have been different at
distinct sites or time points in the infection.
How may RAGE signaling pathways be specifically recruited
in listeriosis? Adaptive RAGE-dependent mechanisms may
contribute to production of interferon-γ. What, then, overrides
the otherwise protective effects of interferon-γ production?
We propose that stimulated macrophages, in addition to
releasing microbial products in the early response to infection
Figure 1
Proposed model of how the receptor for advanced glycation end products (RAGE) mediates tissue injury in listeriosis. Lutterloh and colleagues [1]
show that in polymicrobial gut sepsis and in mice infected with Listeria monocytogenes, RAGE is not essential for host clearance of bacteria. In the
case of listeriosis, macrophages release microbial products in the early response to infection. Although we do not have evidence that bacterial
products directly bind RAGE, we predict that Listeria-infected macrophages release high-mobility group box-1 (HMGB-1) (or perhaps other RAGE
ligands as well). HMGB-1 may stimulate interferon-γ (IFN-γ)-producing cells and thus mediate macrophage activation. Furthermore, HMGB-1 may
directly activate macrophages via RAGE and/or Toll-like receptors (TLRs). Together, these processes synergize to stimulate hyperinflammatory
responses that ultimately cause severe injury to the host. IL-2, interleukin-2.Page 3 of 3
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[11], release the RAGE ligand HMGB-1 [12,13]. HMGB-1,
which may engage TLR-2 and TLR-4 [14], as well as RAGE,
might activate signaling systems that stimulate hyperinflam-
matory responses (Figure 1).
In conclusion, in polymicrobial sepsis and in response to L.
monocytogenes, genetic deletion of RAGE  is remarkably
protective. RAGE is not directly required for bacterial
clearance,  but the compelling experiments of Lutterloh and
colleagues confirm that RAGE action mediates tissue damage
initiated in response to overwhelming bacterial infection.
Future studies must dissect the precise mechanisms by which
RAGE exacts a heavy toll on the host during efforts to
combat pathogenic bacteria.
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